Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06944379
PHASE1

ORKA-002-211 A Phase I Study to Evaluate ORKA-002 in Healthy Volunteers Following A Single Dose

Sponsor: Oruka Therapeutics, Inc.

View on ClinicalTrials.gov

Summary

This is a Phase 1, first-in-human study to evaluate the safety, tolerability, and pharmacokinetics of ORKA-002 in healthy participants.

Official title: Phase 1, First-in-human, Double-blind, Placebo-controlled, Single Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ORKA-002 in Healthy Participants

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2025-05-19

Completion Date

2027-01

Last Updated

2025-09-26

Healthy Volunteers

Yes

Interventions

DRUG

ORKA-002

ORKA-002 is supplied as sterile solution to be administered by SC injection

OTHER

Placebo

Placebo solution to be administered at a matching volume by SC injection

Locations (1)

Oruka Therapeutics Investigative Site

Christchurch, New Zealand, New Zealand